Pan, X., Jin, L., He, T., Hu, J., Quan, J., Zhou, L., Ni, L., Yang, S., Mao, X., & Lai, Y. (2016). Mucinous adenocarcinoma of the bladder: A case report and review of the literature. Molecular and clinical oncology, 5(4), 447–448.
Pan, X., Quan, J., Zhao, L., Li, W., Wei, B., Yang, S., & Lai, Y. (2018). Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report. Molecular and clinical oncology, 8(1), 83–85.
Pan, X., Quan, J., Li, Z., Zhao, L., Zhou, L., Xu, J., Xu, W., Guan, X., Li, H., Yang, S., Gui, Y., & Lai, Y. (2018). miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma. Biomedicine & pharmacotherapy, 102, 718–727.
Pan, X., Li, Z., Zhao, L., Quan, J., Zhou, L., Xu, J., Xu, W., Guan, X., Li, H., Yang, S., Gui, Y., & Lai, Y. (2018). microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis. Oncology reports, 40(5), 3092–3101.
Pan, X., Zhao, L., Quan, J., Liu, K., Lai, Y., Li, Z., Zhang, Z., Xu, J., Xu, W., Guan, X., Li, H., Yang, S., Gui, Y., Chen, Y., & Lai, Y. (2019). MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients. American journal of translational research, 11(4), 2207–2218.
Pan, X., He, T., Peng, X., Li, H., Zhang, F., & Lai, Y. (2020). miR-638 acts as an oncogene and predicts poor prognosis in renal cell carcinoma. American journal of translational research, 12(7), 3645–3659.
Li, H., Pan, X., Gui, Y., Quan, J., Li, Z., Zhao, L., Guan, X., Xu, J., Xu, W., & Lai, Y. (2019). Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery. Cancer biomarkers : section A of Disease markers, 24(2), 153–158.（共一）
Liu, K., Pan, X., Peng, X., Zhang, C., Li, H., Guan, X., Xu, W., Xu, J., Zhao, L., Wang, T., & Lai, Y. (2019). Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients. Pathology, research and practice, 215(6), 152391. （共一）
Peng, X., Pan, X., Liu, K., Zhang, C., Zhao, L., Li, H., Guan, X., Xu, W., Xu, J., Zhang, F., & Lai, Y. (2019). miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery. The International journal of biological markers, 34(3), 302–308. （共一）
Zhang, C., Pan, X., Peng, X., Liu, K., Wang, J., Zhao, L., Chen, X., Huang, G., Li, H., Ye, J., & Lai, Y. (2021). miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer. Journal of clinical laboratory analysis, 35(2), e23599. （共一）
